Home Biosimilar Antibodies Metabolism PCSK9 antibody Frovocimab (Anti-PCSK9) For research use only.
Not for use in humans.

Frovocimab (Anti-PCSK9)

Synonyms: LY 3015014

Frovocimab (Anti-PCSK9) is a humanized IgG4 monoclonal antibody that neutralizes proprotein convertase subtilisin-kexin type 9 (PCSK9). MW: 146.88 KD.

Frovocimab (Anti-PCSK9)

Purity & Quality Control

≥99

Choose Selective PCSK9 Inhibitors

Biological Activity

Description Frovocimab (Anti-PCSK9) is a humanized IgG4 monoclonal antibody that neutralizes proprotein convertase subtilisin-kexin type 9 (PCSK9). MW: 146.88 KD.

Product Details

CAS No. 1643672-70-1
Molecular Weight 146.88
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Frovocimab (Anti-PCSK9) | Frovocimab (Anti-PCSK9) supplier | purchase Frovocimab (Anti-PCSK9) | Frovocimab (Anti-PCSK9) cost | Frovocimab (Anti-PCSK9) manufacturer | order Frovocimab (Anti-PCSK9) | Frovocimab (Anti-PCSK9) distributor